Na Liu

16.1k total citations · 4 hit papers
319 papers, 9.1k citations indexed

About

Na Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Na Liu has authored 319 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Molecular Biology, 100 papers in Cancer Research and 75 papers in Oncology. Recurrent topics in Na Liu's work include Cancer-related molecular mechanisms research (66 papers), RNA modifications and cancer (55 papers) and MicroRNA in disease regulation (45 papers). Na Liu is often cited by papers focused on Cancer-related molecular mechanisms research (66 papers), RNA modifications and cancer (55 papers) and MicroRNA in disease regulation (45 papers). Na Liu collaborates with scholars based in China, United States and Saudi Arabia. Na Liu's co-authors include Jun Ma, Ying‐Qin Li, Yanhong Zhou, J. Jack Lee, Ying Sun, Qing‐Mei He, Yaqin Wang, Lin Chen, Sergey Leonov and Yulia Merkher and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Na Liu

302 papers receiving 9.1k citations

Hit Papers

Recent advances in therapeutic strategies for tri... 2019 2026 2021 2023 2022 2019 2021 2025 100 200 300 400 500

Peers

Na Liu
Dan Li China
Xin Li China
Jian Gu United States
Erik A.C. Wiemer Netherlands
Na Liu
Citations per year, relative to Na Liu Na Liu (= 1×) peers Xiaohong Wang

Countries citing papers authored by Na Liu

Since Specialization
Citations

This map shows the geographic impact of Na Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Liu more than expected).

Fields of papers citing papers by Na Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Liu. The network helps show where Na Liu may publish in the future.

Co-authorship network of co-authors of Na Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Na Liu. A scholar is included among the top collaborators of Na Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Liu. Na Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Na, Y.D. Tu, Hanyu Wang, et al.. (2025). Reactivating T cell immunity in Wnt-hyperactivated non-small cell lung cancer through a supramolecular droplet of carnosic acid and peptide. Journal of Pharmaceutical Analysis. 15(12). 101309–101309. 1 indexed citations
2.
Xu, Hui, Na Liu, Qian Wang, et al.. (2025). Ferrous Fumarate-Encapsulated Nanoformulation Triggering a Domino Effect for Enhanced Ferroptosis Therapy. ACS Applied Materials & Interfaces. 17(20). 29379–29391.
3.
Li, Qingjie, Xueliang Fang, Yingqin Li, et al.. (2024). DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma. Advanced Science. 11(36). e2403262–e2403262. 10 indexed citations
4.
Liu, Na, et al.. (2024). The signal peptide of BmNPV GP64 activates the ERAD pathway to regulate heterogeneous secretory protein expression. Microbial Cell Factories. 23(1). 284–284. 1 indexed citations
5.
Liu, Na, Xiaoqiang Zheng, Jin Yan, et al.. (2024). Reversing MET‐Mediated Resistance in Oncogene‐Driven NSCLC by MET‐Activated Wnt Condensative Prodrug. Advanced Science. 11(30). e2400603–e2400603. 5 indexed citations
6.
Rong, Li, Shunle Li, Lin Shen, et al.. (2024). LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification. Ecotoxicology and Environmental Safety. 285. 117064–117064. 10 indexed citations
7.
Fang, Xueliang, Qingjie Li, Chenglong Huang, et al.. (2024). Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma. Cell Death and Disease. 15(2). 112–112. 3 indexed citations
8.
Yue, Wei, et al.. (2023). Treatment duration of wrist-ankle acupuncture for relieving post-thyroidectomy pain: A randomized controlled trial. Journal of Integrative Medicine. 21(2). 168–175. 6 indexed citations
9.
Li, Qian, Cheng Xu, Ye‐Lin Liang, et al.. (2023). Chemotherapy‐Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA‐Mediated PKR Activation. Advanced Science. 10(8). e2205668–e2205668. 35 indexed citations
10.
Zhao, Yin, Sha Gong, Miaomiao Wang, et al.. (2023). TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nature Communications. 14(1). 865–865. 73 indexed citations
11.
Zheng, Zi‐Qi, Zhi‐Xuan Li, Xu Liu, et al.. (2020). Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance. Cancer Research. 80(23). 5174–5188. 86 indexed citations
12.
Hong, Xiao-Hong, Na Liu, Ye‐Lin Liang, et al.. (2020). Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Molecular Cancer. 19(1). 33–33. 159 indexed citations
13.
Liu, Shouping, Weiwei Lai, Ying Shi, et al.. (2020). Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers. npj Precision Oncology. 4(1). 5–5. 13 indexed citations
14.
Zheng, Zi‐Qi, Zhi‐Xuan Li, Guan‐Qun Zhou, et al.. (2019). Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3. Cancer Research. 79(18). 4612–4626. 279 indexed citations
15.
Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 26(11). 2329–2343. 429 indexed citations breakdown →
16.
Li, Ying-Qin, Xiao-Jing Yang, Xiaojing Du, et al.. (2018). RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma. Clinical Cancer Research. 24(24). 6495–6508. 24 indexed citations
17.
Zhang, Jiän, Ying-Qin Li, Rui Guo, et al.. (2018). Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability. Cancer Research. 79(4). 747–759. 35 indexed citations
19.
Ren, Xianyue, Guan‐Qun Zhou, Wei Jiang, et al.. (2015). Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC. Cancer Prevention Research. 8(10). 968–977. 30 indexed citations
20.
Liu, Na, Ning Jiang, Rui Guo, et al.. (2013). MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Molecular Cancer. 12(1). 123–123. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026